Search Results

You are looking at 1 - 10 of 325 items for :

  • long-term follow-up x
Clear All
Open access

Mojca Jensterle, Nika Aleksandra Kravos, Simona Ferjan, Katja Goricar, Vita Dolzan and Andrej Janez

drop-outs and the effects that may have on the study outcome. However, this attrition rate was similar to that from other studies on PCOS ( 16 , 30 ). The main strength of this study is the long-term longitudinal follow-up assessing the effectiveness

Open access

Alberto Giacinto Ambrogio, Massimiliano Andrioli, Martina De Martin, Francesco Cavagnini and Francesca Pecori Giraldi

desmopressin disappeared in all but 6 patients, 4 long-term remissions (last follow-up 44–94 months) and 2 relapses ( Fig. 1 ). Overall, the ACTH response to desmopressin was comparable between patients on long-term remission and relapses (incremental peak 14

Open access

Prachi Bansal, Anurag Lila, Manjunath Goroshi, Swati Jadhav, Nilesh Lomte, Kunal Thakkar, Atul Goel, Abhidha Shah, Shilpa Sankhe, Naina Goel, Neelam Jaguste, Tushar Bandgar and Nalini Shah

predictive of remission in various studies ( 4 , 5 , 6 ). Recurrence of CD following remission after TSS is a well-recognised phenomenon and is reported to be as high as 15–66% in various long-term studies ( 7 ), emphasising the need for long-term follow-up

Open access

Cristina Lamas, Elena Navarro, Anna Casterás, Paloma Portillo, Victoria Alcázar, María Calatayud, Cristina Álvarez-Escolá, Julia Sastre, Evangelina Boix, Lluis Forga, Almudena Vicente, Josep Oriola, Jordi Mesa and Nuria Valdés

, recurrence and reoperations). Follow-up is considered from surgery to the last follow-up visit in operated patients and from diagnosis in non-operated patients. Only patients with long-term follow-up are considered for recurrence and permanent

Open access

Nadine M Vaninetti, David B Clarke, Deborah A Zwicker, Churn-Ern Yip, Barna Tugwell, Steve Doucette, Chris Theriault, Khaled Aldahmani and Syed Ali Imran

subsequent imaging and SHD status were compared to identify any significant change. Mean follow-up period was 5.7 years for CMSM and 5.0 years for PI. In this study, we have reported the long-term follow-up and outcomes of NFA and non-pituitary SM only while

Open access

Lauren E Henke, John D Pfeifer, Thomas J Baranski, Todd DeWees and Perry W Grigsby

our findings and the literature is that prior studies suffered small patient cohorts and were underpowered. Our much larger patient cohort, in addition to extensive follow-up time, likely enabled us to expose these significant differences in long-term

Open access

Logan Mills, Panagiotis Drymousis, Yogesh Vashist, Christoph Burdelski, Andreas Prachalias, Parthi Srinivasan, Krishna Menon, Corina Cotoi, Saboor Khan, Judith Cave, Thomas Armstrong, Martin O Weickert, Jakob Izbicki, Joerg Schrader, Andreja Frilling, John K Ramage and Raj Srirajaskanthan

to 6 years after diagnosis, long-term follow-up is clearly necessary in order to assess the safety ( 8 ). Table 6 Data extracted from all studies reporting a period of observation of small, non-functioning pNETs. Surveillance

Open access

Adriano N Cury, Verônica T Meira, Osmar Monte, Marília Marone, Nilza M Scalissi, Cristiane Kochi, Luís E P Calliari and Carlos A Longui

and interference with reproductive function (3) . The purpose of this study was to evaluate the efficacy and long-term follow-up safety of RAI therapy in GD patients aged under 19 years. Like other centers, our protocol for 131 I for GD is based on

Open access

Jens P Goetze, Linda M Hilsted, Jens F Rehfeld and Urban Alehagen

comprised those who had died due to cardiovascular disease. The assumption of proportionality was tested as long follow-up. As the assumption was not fulfilled, we chose to present mortality data in two steps: short-term mortality with a follow-up time of 3

Open access

Helle Døssing, Finn Noe Bennedbæk and Laszlo Hegedüs

this long-term follow-up after LT therapy, for a benign cystic-solid thyroid nodule. Results for patients in the surgery group The decision of subsequent surgery was based on persistent nodule-related compressive symptoms and/or cosmetic